MediLabSecure. Maria Grazia Dente and Silvia Declich National Center for Global Health Istituto Superiore di Sanità

Similar documents
Establishment of networks of human and animal virology laboratories and medical entomology

Overview on Lumpy skin disease in the Mediterranean region: From Middle East to Europe

GENERAL CONSIDERATIONS OF ANIMAL DISEASE PREVENTION FOR THE BALKAN PENINSULA THE BULGARIAN POINT OF VIEW

Progress report on emerging and re-emerging diseases including dengue and dengue haemorrhagic fever

Integrated surveillance of vector borne diseases The example of WNV surveillance in Italy

Health Security Workshop: How to benefit from European projects?

The European Neighbourhood Policy (ENP) ENP Coordination External Relations Directorate General European Commission

Enhancing prevention and control of Rift Valley Fever in East Africa by intersectoral assessment of control options

Recent RVF outbreaks in North Western Africa Alessandro Ripani OIE Sub Regional Representation for North Africa Tunis, Tunisia

West Nile virus circulation in the EpiSouth countries and neighbouring areas (Hungary and Russia) Update 6 th of October 2010

Southeast European Center for Surveillance and Control of Infectious Diseases (SECID)

Emerging global health threats of animal origin

MediLabSecure. 2 nd Technical Workshop on Public Health: Multisector Rapid Risk Assessment for Crimean-Congo Haemorrhagic Fever

Rift valley fever, viral haemorrhagic fevers and others emerging zoonotic diseases.

EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL?

Paper on needs and support to be provided to North African countries, members of REMESA regarding the coordinated control of FMD

Protecting European citizen s health ECDC, an added value for the OCTs?

Upgrade of the EPIS-FWD system: Concept and concrete features

Ongoing Lumpy Skin Disease activities. Drago Marojevic, DVM

Preliminary Programme Be E.I.! 2013 Meeting of ECDC National Focal Points for Threat Detection

2004, OIE initiative Ad hoc Group on Antigen & Vaccine Banks for FMD

Lumpy skin disease (LSD) Epidemiological situation in Europe (update since LSD4)

Lumpy skin disease follow-up project proposal

Travel and transport risk assessment. Preparedness for potential outbreak of

Communicable diseases in the Mediterranean region

Lumpy skin disease (LSD) Epidemiological situation in Europe (update since LSD2)


Episouth plus Project Mediterranean Regional Lab Network (MRLN)

Rift Valley Fever (RVF) outbreak Yirol East, Eastern Lakes State, Republic of South Sudan

Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010.

Workshop on Health Statistics. Annotations for the Agenda. Venue : Union internationale des chemins de fer (UIC P) Centre de conférence

Mo Salman Animal Population Health Institute, Colorado State University, Fort Collins, Colorado, , USA

HPAI H5(N8) in Member States in poultry, captive and wild birds

Lumpy skin disease (LSD) Vaccination Data Collection

The role of National Influenza Centres (NICs) during Interpandemic, Pandemic Alert and Pandemic Periods

FAO Lumpy Skin Disease projects overview

Lumpy skin disease (LSD) & Sheep Pox. State of play in the EU

Preparedness plan against Chikungunya and dengue dissemination in mainland France Public Health perspective

Current Situation on Avian Influenza and the pandemic threat

Avian Influenza Prevention and Preparedness: Global and Regional Strategies and Actions

Introduction to the Global AMR Action Plan

One World One Health TM

Issue No. 9, December 2013

EURO POLIO PAGE Data as of 04 October 2005 (Week 38)

Arbovirus Surveillance: Present and Future

Lumpy skin disease (LSD)

Updates from the European Centre for Disease Prevention and Control

Seventh GF-TADs for Europe Steering Committee meeting (RSC7)

Animal and Zoonotic Disease Surveillance Systems: FAO/OIE/WHO Global Early Warning and Response System (GLEWS)

DG SANTE actions under the CBRN Action Plan

Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens WORKSHOP ON PRIORITIZATION OF PATHOGENS

Name: Mah d M. S. Shafei Tel:

Lumpy skin disease: Scientific report

The FAO/OIE FMD Global Control Strategy Joseph Domenech, OIE on behalf of the joint FAO/OIE GF TADs PPR Working Group

External Quality Assurance: Subregional experiences on RVF

OIE Situation Report for Avian Influenza

Dr Ghazi Yehia OIE Regional Representative for the Middle East

Risk assessment group (RAG), between

Weekly Epidemiological Report for the West Nile virus disease, Greece, October 2013

WEST NILE VIRUS AND OTHER MOSQUITO-BORNE DISEASE NATIONAL SURVEILLANCE REPORT

Preventing disease Promoting and protecting health

Summary report on the WHO-EM/CSR/124/E

Regional workshop on updating national strategic plans for the prevention of re-establishment of local malaria transmission in malaria-free countries

Weekly Epidemiological Report for West Nile Virus disease, Greece, July

Summary. Primary care data. Week 49/2014. Season

Progress in Flour Fortification in Central and Eastern Europe and Commonwealth of Independent States

West Nile Virus Surveillance in mosquito vectors (Culex pipiens)

Climate changes and animal infectious diseases

High Level Summary and Recommendations

EVALUATION OF HEALTH THREATS: How the EU system functions Zsuzsanna Jakab, Director of ECDC, Informal Meeting of Health Ministers

Regional contributions and synergies for. Global Health Security. Abstracts Book. 27th Nov - 1st Dec Brussels, Belgium

Arbovirus Infections and the animal reservoir

Standing Group of Experts on LSD in South-East Europe

WEST NILE VIRUS AND OTHER MOSQUITO-BORNE DISEASE NATIONAL SURVEILLANCE REPORT

Addressing climate change driven health challenges in Africa

Information about activities in the region of possible relevance for the regional strategic plan. GF-TADs for Europe

Overview on Lumpy skin disease in the Mediterranean region: From Middle East to Europe

FIRST MEETING OF THE TECHNICAL ADVISORY GROUP ON PUBLIC HEALTH ENTOMOLOGY PAN AMERICAN HEALTH ORGANIZATION

Introduction to Influenza Pandemic Planning

Multi-sectoral aspects of pandemic preparedness and response

WEST NILE VIRUS AND OTHER MOSQUITO-BORNE DISEASE NATIONAL SURVEILLANCE REPORT

EFSA projects on PPR, sheep pox, lumpy skin disease. Franck Berthe Animal and Plant Health Unit European Food Safety Authority - EFSA

Arboviral Surveillance and Control Annual Report: Pennsylvania, 2014

Gender Statistics Programme of the United Nations Economic Commission for Europe

Pandemic Preparedness

Achieving the United Nations 2030 Sustainable Development Goals, Health 2020 and the SEE 2020 goals: how to make it happen?

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

Submission Date: 23 June 2010 at: 11:40

Pillar 2: Reduce Risk to members from the FMD Situation in the European Neighbourhood Accomplishments and Lessons Learned

International Emerging Infections Program A Program to Build Capacity to Address Emerging Infections in Africa

The OIE approach to One Health

Regional Prospective of Vaccine Procurement in SEE Countries

THE SITUATION OF YELLOW FEVER IN THE AFRICAN REGION: THE PLAN TO END YF EPIDEMICS IN 2026

Activities in 2010, Priorities for 2011

Rift Valley Fever (RVF) outbreak Yirol East, Eastern Lakes State, Republic of South Sudan

4.3.9 Pandemic Disease

Disease Prevention, Detection & Response During Public Health Emergencies

- Foot and Mouth Disease Simulation Exercises in the Balkan countries

Events detected by national surveillance system (see Annex 1)

Alcohol-related harm in Europe and the WHO policy response

Transcription:

MediLabSecure Maria Grazia Dente and Silvia Declich National Center for Global Health Istituto Superiore di Sanità The ASSET FINAL EVENT Share and move for mobilization and mutual learning at local, national and international levels on Science in Society related issues in epidemics and pandemics Rome, 30-31.10.2017

MediLabSecure aims at increasing the health security in the Mediterranean and Black Sea Regions by enhancing and strengthening the preparedness to common health threats. Cluster 1: Emerging viruses with vector transmission Cluster 2: Emerging respiratory viruses with possible animal transmission WP4 Medical Entomology WP2 Animal virology WP3 Human Virology and Biosafety WP 5 Public Health

One Health Network Human Virology Public Health Medical Entomology Animal Virology

The Network The network comprises 55 laboratories and 19 public health institutions/ministries of health (EpiSouth Network) of 19 non-eu countries in the Mediterranean and Black Sea regions.

.the desired impact of the One Health approach expected through intersectoral integration can only be achieved if also the capacities of each involved sector are sufficiently strong and developed (Häsler B, Gilbert W, Jones BA, Pfeiffer DU, Rushton J, Otte MJ. The economic value of One Health in relation to the mitigation of zoonotic disease risks. Curr Top Microbiol Immunol. 2012;365:127 51). MedilabSecure is working with a comprehensive strategy addressing both the capacity of the single sector and the intersectoral integration.

Main activities Workshops (lab+field) (10) Molecular and serological diagnostic tools for the detection of arboviruses Molec. analysis of zoonotic arboviruses Capacity building in mosquito vectors of arboviruses Vector-borne viruses multisectoral risk assessment and integrated surveillance Biorisk management and infectious substances shipment 159 participants 68 training staff 302 hours theoretical and practical training Qualitative study Situation analysis on integrated surveillance of arboviruses in the Mediterranean and Black Sea regions Online atlas Interactive key for mosquitoes identification EQAs PCR (WNV, ChikV) Serology (WNV, RVFV, ChikV) Mosquitoes identification Networking: 14 meetings Coordination meetings General meetings Kick-off Heads of laboratories Mid-term meeting 2 regional meetings Experts visits Dissemination: > 35 actions 1 scientific paper 1 position paper 1 travelling exhibition 27 presentations at conferences (oral and poster) 6 Participation to other project meetings (WHO, ECDC, etc) One Health day labelling

Public Health Group Aim Public health activities reinforce the preparedness of MediLabSecure Network by strengthening: integrated surveillance, multisector risk assessment and early case detection of arboviral diseases in the framework of One Health.

Public Health Group Activities Integrated Surveillance To identify criteria to define integrated surveillance and to compare different systems: A Scoping Review A Survey with Medilabsecure members A Situation analysis in the Mediterranean and Black Sea Regions Integrated Risk Assessments

Risk assessment exercises: Objectives To foster small group discussion on the status of priorities arboviruses in the region and to assess level of risks at country level To enhance knowledge on multisector Risk Assessment (RA) for: - West Nile Virus disease (1 st exercise, Paris 2015) - Crimean-Congo Haemorrhagic Fever (2 nd exercise, Belgrade 2016) - Rift Valley Fever (3 rd exercise, Tunis 2017) To make the participants aware of available RA methodologies and tools: - the ECDC Tool for RA for WNV (1 st exercise, Paris 2015) - the ECDC guidance on Rapid RA (2 nd exercise, Belgrade 2016) - FAO RA methodology (3 rd exercise, Tunis 2017)

main results: 1 exercise - WNV The exercise involved 73 participants divided in 6 small groups by country according to regional proximity: Groups Group 1 Group 2 Group 3 Group 4 Group 5 Group 6 Name Black Sea 1 Black sea 2 North Africa Balkans 1 Balkans 2 Middle East N. Participants 9 8 14 11 14 17 Countries Moldova, Ukraine Armenia, Georgia Algeria, Morocco, Tunisia, Egypt Albania, Bosnia- Herzegovina, Kosovo Montenegro, Serbia, R. Macedonia Palestine, Turkey, Jordan, Lebanon

main results: 1 exercise - WNV Each participant was asked to identify the risk area that is mostly representative of his/her country on a wall poster using sticky dots (dots colour according to the sector) using the following table from the ECDC tool: Seasonal risk levels of WNV transmission to humans (ECDC Tool)

main results: 1 exercise - WNV example risk scoring result by regional group

main results: 2 exercise - CCHF The exercise involved 42 participants divided in 3 small groups by country : Groups Group 1 Group 2 Group 3 N. 18 15 9 Participants Countries Serbia Albania Former Yugoslav Republic of Macedonia Georgia Armenia Moldova Kosovo Ukraine Montenegro Turkey Bosnia and Herzegovina

main results: 2 exercise - CCHF

Level of risk assessed (Low/medium/high) main results: 2 exercise - CCHF Added value of multi-sector approach for each of the questions of the assessment (Low/medium/high) 1. Is this threat unusual or unexpected? (high 10/11) 2. What is the potential for transmission within your country? (high 9/11) 3. Is it likely to cause severe disease in the population? (high 6/11) 4. Are effective treatments and control measures available? (high 5/11) 5. Are there contextual factors that may affect the risk assessment? (high 10/11) Group 1 Low high high medium low high Moderate high high high low high Moderate high high medium low high Group 2 Low high high high high high Low/Moderate high high medium medium high Moderate high high High medium high Moderate/high high medium high high high Moderate/high high high high high high Group 3 Low high high high medium medium Moderate medium medium medium high high Moderate high high medium high high

main results: 3 exercise - RVF The exercise involved 44 participants divided in 3 small groups by country : Groups Group 1 Group 2 Group 3 N. Participants (excluding facilitators) 13 15 16 Countries Morocco Algeria Tunisia Libya Egypt Tunisia Jordan Lebanon Palestine Tunisia [1] Being the Meeting in Tunisia, Tunisia was over represented in the groups. In fact 19 Tunisian referents were involved in the Exercise out of the 44 total participants

main results: 3 exercise - RVF Risk Assessment Questions: Q.1.a Which risk factors affect the occurrence, persistence and spread of RVF infection in Africa and other areas with a history of RVF infection or outbreak? Q.1.b Which risk factors affect the spread of RVF infection into new areas? Q.2 Which preparedness measures could be put in place to reduce the risk of RVF virus infection in Africa and other at risk areas? Q.3 Which prevention and control options can be put in place to reduce the impact of RVF spreading? Q.4.a What is the risk of RVF virus infection introduction to your country in the next 3 5 years? Q.4.b What is the risk of the RVF virus persisting and spreading once introduced into your country?

main results: 3 exercise - RVF Added value of the multisector approach: Almost all the countries considered that doing the assessment with a multisector approach had a high added value for the questions 1 (a. and b.), 2, and 3. In other words, the replies to the question 1, 2 and, 3, were highly facilitated by the concomitant presence of different sectors (human, animal and entomological) at the assessment. This has ensured a comprehensive discussion aimed at filling gaps and decreasing uncertainty. Q.1.a Which risk factors affect the occurrence, persistence and spread of RVF infection in Africa and other areas with a history of RVF infection or outbreak? Q.1.b Which risk factors affect the spread of RVF infection into new areas? Q.2 Which preparedness measures could be put in place to reduce the risk of RVF virus infection in Africa and other at risk areas? Q.3 Which prevention and control options can be put in place to reduce the impact of RVF spreading?

Risk assessment exercises: lessons learned Valorisation, dissemination and utilisation of available methodologies and tools on RA should be promoted at national level also to evaluate the appropriateness of these methodologies and tools in national contexts Multisector RA fosters discussion between the different sectors involved in the surveillance of arboviruses and enhances awareness on reciprocal roles, expertise and procedures Sectors coordination/collaboration contributes to the assessment of the risks especially in case of lack of relevant documentation and updated information

Thanks for your attention! The MediLabSecure Project is supported by the European Commission (DEVCO: IFS/21010/23/_194)